FI944933L - 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sitä sisältäviä farmaseuttisia käyttöjä ja koostumuksia - Google Patents
7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sitä sisältäviä farmaseuttisia käyttöjä ja koostumuksia Download PDFInfo
- Publication number
- FI944933L FI944933L FI944933A FI944933A FI944933L FI 944933 L FI944933 L FI 944933L FI 944933 A FI944933 A FI 944933A FI 944933 A FI944933 A FI 944933A FI 944933 L FI944933 L FI 944933L
- Authority
- FI
- Finland
- Prior art keywords
- pyrrolo
- pyrimidine
- oxo
- same
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87144192A | 1992-04-21 | 1992-04-21 | |
| PCT/US1993/002841 WO1993021187A1 (en) | 1992-04-21 | 1993-03-25 | 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI944933A7 FI944933A7 (fi) | 1994-10-20 |
| FI944933A0 FI944933A0 (fi) | 1994-10-20 |
| FI944933L true FI944933L (fi) | 1994-10-20 |
Family
ID=25357439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI944933A FI944933L (fi) | 1992-04-21 | 1993-03-25 | 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sitä sisältäviä farmaseuttisia käyttöjä ja koostumuksia |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0638080A4 (fi) |
| JP (1) | JPH07507062A (fi) |
| KR (1) | KR950701335A (fi) |
| AU (1) | AU4276693A (fi) |
| CA (1) | CA2133346A1 (fi) |
| FI (1) | FI944933L (fi) |
| HU (1) | HUT71559A (fi) |
| NO (1) | NO303637B1 (fi) |
| RU (1) | RU94046387A (fi) |
| WO (1) | WO1993021187A1 (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19709877A1 (de) * | 1997-03-11 | 1998-09-17 | Bayer Ag | 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate |
| CA2288317A1 (en) * | 1997-05-29 | 1998-12-03 | Benjamin Biro Mugrage | 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo¬3,2-d|pyrimidin-4-ones |
| US6355244B1 (en) | 1997-11-17 | 2002-03-12 | University Of Kentucky Research Foundation | Methods and compositions for the treatment of psoriasis |
| US6174888B1 (en) | 1998-05-28 | 2001-01-16 | Novartis Ag | 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones |
| GB0215392D0 (en) * | 2002-07-03 | 2002-08-14 | Glaxo Group Ltd | Chemical compounds |
| JP4570566B2 (ja) * | 2003-08-26 | 2010-10-27 | 帝人ファーマ株式会社 | ピロロピリミジノン誘導体 |
| US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
| MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| US7763257B2 (en) | 2004-12-09 | 2010-07-27 | Christina Juneau | Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products |
| US8466151B2 (en) | 2007-12-26 | 2013-06-18 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
| CA2730890C (en) | 2008-07-17 | 2018-05-15 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| EP2552915B1 (en) | 2010-04-01 | 2017-07-19 | Critical Outcome Technologies Inc. | Compounds for the treatment of hiv |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU654264B2 (en) * | 1989-10-31 | 1994-11-03 | Biocryst Pharmaceuticals, Inc. | Inhibitors of purine nucleoside phosphorylase |
| US5189039A (en) * | 1989-11-29 | 1993-02-23 | Biocryst, Inc. | 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same |
-
1993
- 1993-03-25 CA CA002133346A patent/CA2133346A1/en not_active Abandoned
- 1993-03-25 HU HU9403021A patent/HUT71559A/hu unknown
- 1993-03-25 KR KR1019940703788A patent/KR950701335A/ko not_active Ceased
- 1993-03-25 FI FI944933A patent/FI944933L/fi not_active Application Discontinuation
- 1993-03-25 JP JP5518357A patent/JPH07507062A/ja active Pending
- 1993-03-25 EP EP93912081A patent/EP0638080A4/en not_active Withdrawn
- 1993-03-25 WO PCT/US1993/002841 patent/WO1993021187A1/en not_active Ceased
- 1993-03-25 RU RU94046387/04A patent/RU94046387A/ru unknown
- 1993-03-25 AU AU42766/93A patent/AU4276693A/en not_active Abandoned
-
1994
- 1994-10-20 NO NO943988A patent/NO303637B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993021187A1 (en) | 1993-10-28 |
| CA2133346A1 (en) | 1993-10-28 |
| RU94046387A (ru) | 1996-09-27 |
| EP0638080A1 (en) | 1995-02-15 |
| FI944933A7 (fi) | 1994-10-20 |
| FI944933A0 (fi) | 1994-10-20 |
| JPH07507062A (ja) | 1995-08-03 |
| HUT71559A (en) | 1995-12-28 |
| NO943988L (no) | 1994-10-20 |
| KR950701335A (ko) | 1995-03-23 |
| NO943988D0 (no) | 1994-10-20 |
| EP0638080A4 (en) | 1995-08-23 |
| NO303637B1 (no) | 1998-08-10 |
| AU4276693A (en) | 1993-11-18 |
| HU9403021D0 (en) | 1994-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL106431A0 (en) | Aminediol derivatives and pharmaceutical compositions containing the same | |
| IL106927A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
| DE69325333D1 (de) | Antivirale Zusammensetzung | |
| PH25932A (en) | Adenosine derivatives and pharmaceutical compositions containing the same | |
| IL106624A0 (en) | Asymmetrically substituted xanthines,their preparation and pharmaceutical compositions containing them | |
| IL110743A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| PT589843E (pt) | Composicoes farmaceuticas contendo ciclosporinas | |
| PH30439A (en) | 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same | |
| IL110988A0 (en) | 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same | |
| NZ236625A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
| PH27460A (en) | Pyrimidine derivatives and herbicidal composition containing the same | |
| IL94821A0 (en) | Monosaccharide compounds and pharmaceutical compositions containing the same | |
| PH21540A (en) | Cholecalciferol derivatives and pharmaceutical compositions containing the same | |
| FI944933L (fi) | 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sitä sisältäviä farmaseuttisia käyttöjä ja koostumuksia | |
| DE4294862T1 (de) | Pharmazeutische Komposition | |
| IL110509A0 (en) | Pyrimido pyrimidine compounds, their preparation and pharmaceutical compositions containing them | |
| ZA941088B (en) | Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them | |
| EP0180190A3 (en) | 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same | |
| IL89376A0 (en) | Substituted pyrimidines,their preparation and pharmaceutical compositions containing them | |
| HUP9903526A3 (en) | Pyrimidine derivatives and pharmaceutical compositions containing the same | |
| IL104944A0 (en) | Anti-tumor agents and pharmaceutical compositions containing the same | |
| GB2216794B (en) | Pharmaceuticals compositions | |
| FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
| PH21779A (en) | Sulfonomidines and pharmaceutical compositions containing the same | |
| IL59987A (en) | Antianginal compositions containing 3-substituted-tetrahydro-pyrrolo(1,2-a)pyrimidinone derivatives and some new 3-substituted-tetrahydro-pyrrolo(1,2-a)pyrimidin-2-ones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |